The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Low-grade gliomas in adults: A review
Abstract
In recent years, advances in the understanding of low-grade glioma (LGG) biology have driven new paradigms in molecular markers, diagnostic imaging, operative techniques and technologies, and adjuvant therapies. Taken together, these developments are collectively pushing the envelope toward improved quality of life and survival. In this article, the authors evaluate the recent literature to synthesize a comprehensive review of LGGs in the modern neurosurgical era.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Genetic Pathways to Primary and Secondary Glioblastoma
Ohgaki, H., & Kleihues, P. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070011 · Cited by 1,497
Ojemann, G., Ojemann, J., Lettich, E., & Berger, M. (1989) · Journal of Neurosurgery · doi:10.3171/jns.1989.71.3.0316 · Cited by 1,489
Self-citationOhgaki, H., & Kleihues, P. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.6.479 · Cited by 1,381
GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME
Sanai, N., & Berger, M. S. (2008) · Neurosurgery · doi:10.1227/01.neu.0000318159.21731.cf · Cited by 1,328
Self-citationRole of extent of resection in the long-term outcome of low-grade hemispheric gliomas
Smith, J. S., Chang, E. F., Lamborn, K. R., Chang, S. M., Prados, M. D., Cha, S., Tihan, T., VandenBerg, S., McDermott, M. W., & Berger, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9337 · Cited by 1,283
Self-citationGenetic Pathways to Glioblastoma
Ohgaki, H., Dessen, P., Jourde, B., Horstmann, S., Nishikawa, T., Di Patre, P.-L., Burkhard, C., Schüler, D., Probst-Hensch, N. M., Maiorka, P. C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1337 · Cited by 1,270
Hartmann, C., Meyer, J., Balss, J., Capper, D., Mueller, W., Christians, A., Felsberg, J., Wolter, M., Mawrin, C., Wick, W., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0561-9 · Cited by 1,163
Functional Outcome after Language Mapping for Glioma Resection
Sanai, N., Mirzadeh, Z., & Berger, M. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067819 · Cited by 1,065
Self-citationNeural Stem Cells and the Origin of Gliomas
Sanai, N., Alvarez-Buylla, A., & Berger, M. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043666 · Cited by 1,044
Self-citationvan den Bent, M., Afra, D., de Witte, O., Hassel, M. B., Schraub, S., Hoang-Xuan, K., Malmström, P.-O., Collette, L., Piérart, M., Mirimanoff, R., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67070-5 · Cited by 1,035
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas
Watanabe, T., Nobusawa, S., Kleihues, P., & Ohgaki, H. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080958 · Cited by 1,027
Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma
Pignatti, F., van den Bent, M., Curran, D., Debruyne, C., Sylvester, R., Therasse, P., Áfra, D., Cornu, P., Bolla, M., Vecht, C., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.121 · Cited by 955
Epidemiology and molecular pathology of glioma
Schwartzbaum, J. A., Fisher, J. L., Aldape, K. D., & Wrensch, M. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0289 · Cited by 949
Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium
Bondy, M. L., Scheurer, M. E., Malmer, B., Barnholtz-Sloan, J. S., Davis, F. G., Il'yasova, D., Kruchko, C., McCarthy, B. J., Rajaraman, P., Schwartzbaum, J. A., et al. (2008) · Cancer · doi:10.1002/cncr.23741 · Cited by 932
Jenkins, R. B., Blair, H., Ballman, K. V., Giannini, C., Arusell, R. M., Law, M., Flynn, H., Passe, S., Felten, S., Brown, P. D., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1796 · Cited by 763
Shaw, E., Arusell, R., Scheithauer, B., O’Fallon, J., O’Neill, B., Dinapoli, R., Nelson, D., Earle, J., Jones, C., Cascino, T., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.126 · Cited by 730
Cairncross, G., Berkey, B., Shaw, E., Jenkins, R., Scheithauer, B., Brachman, D., Buckner, J., Fink, K., Souhami, L., Laperierre, N., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3414 · Cited by 728
Karim, A. B. M. F., Maat, B., Hatlevoll, R., Menten, J., Rutten, E. H. J. M., Thomas, D. G. T., Mascarenhas, F., Horiot, J. C., Parvinen, L. M., van Reijn, M., et al. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00352-5 · Cited by 694
Duffau, H. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70140-x · Cited by 683
McGirt, M. J., Chaichana, K. L., Attenello, F. J., Weingart, J. D., Than, K., Burger, P. C., Olivi, A., Brem, H., & Quinoñes-Hinojosa, A. (2008) · Neurosurgery · doi:10.1227/01.neu.0000325729.41085.73 · Cited by 533
Seizure characteristics and control following resection in 332 patients with low-grade gliomas
Chang, E. F., Potts, M. B., Keles, G. E., Lamborn, K. R., Chang, S. M., Barbaro, N. M., & Berger, M. S. (2008) · Journal of Neurosurgery · doi:10.3171/jns/2008/108/2/0227 · Cited by 526
Self-citationKeles, G. E., Lamborn, K. R., & Berger, M. S. (2001) · Journal of Neurosurgery · doi:10.3171/jns.2001.95.5.0735 · Cited by 488
Self-citationClaus, E. B., Horlacher, A., Hsu, L., Schwartz, R. B., Dello‐Iacono, D., Talos, F., Jolesz, F. A., & Black, P. M. (2005) · Cancer · doi:10.1002/cncr.20867 · Cited by 454
Duffau, H., & Capelle, L. (2004) · Cancer · doi:10.1002/cncr.20297 · Cited by 443
Epilepsy in low‐grade gliomas: The impact on cognitive function and quality of life
Klein, M., Engelberts, N. H. J., van der Ploeg, H. M., Kasteleijn‐Nolst Trenité, D. G. A., Aaronson, N. K., Taphoorn, M. J. B., Baaijen, H., Vandertop, W. P., Muller, M., Postma, T. J., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10712 · Cited by 423
Limitations of stereotactic biopsy in the initial management of gliomas
Jackson, R. J., Fuller, G. N., Abi-Said, D., Lang, F. F., Gokaslan, Z. L., Shi, W. M., Wildrick, D. M., & Sawaya, R. (2001) · Neuro-Oncology · doi:10.1093/neuonc/3.3.193 · Cited by 416
Karim, A. B. M. F., Afra, D., Cornu, P., Bleehan, N., Schraub, S., De Witte, O., Darcel, F., Stenning, S., Pierart, M., & Van Glabbeke, M. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)02692-x · Cited by 389
Keles, G. E., Lundin, D. A., Lamborn, K. R., Chang, E. F., Ojemann, G., & Berger, M. S. (2004) · Journal of Neurosurgery · doi:10.3171/jns.2004.100.3.0369 · Cited by 380
Self-citationGiussani, C., Roux, F.-E., Ojemann, J., Sganzerla, E. P., Pirillo, D., & Papagno, C. (2010) · Neurosurgery · doi:10.1227/01.neu.0000360392.15450.c9 · Cited by 378
Leighton, C., Fisher, B., Bauman, G., Depiero, S., Stitt, L., MacDonald, D., & Cairncross, G. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1294 · Cited by 365
Wu, J.-S., Zhou, L.-F., Tang, W.-J., Mao, Y., Hu, J., Song, Y.-Y., Hong, X.-N., & Du, G.-H. (2007) · Neurosurgery · doi:10.1227/01.neu.0000303189.80049.ab · Cited by 361
Hoang-Xuan, K., Capelle, L., Kujas, M., Taillibert, S., Duffau, H., Lejeune, J., Polivka, M., Crinière, E., Marie, Y., Mokhtari, K., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.169 · Cited by 356
Sanai, N., Polley, M.-Y., & Berger, M. S. (2010) · Journal of Neurosurgery · doi:10.3171/2009.6.jns0952 · Cited by 349
Self-citationKRAUS, J. A., KOOPMANN, J., KASKEL, P., MAINTZ, D., BRANDNER, S., SCHRAMM, J., LOUIS, D. N., WIESTLER, O. D., & VON DEIMLING, A. (1995) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199501000-00011 · Cited by 349
Okamoto, Y., Di Patre, P.-L., Burkhard, C., Horstmann, S., Jourde, B., Fahey, M., Schüler, D., Probst-Hensch, N. M., Yasargil, M. G., Yonekawa, Y., et al. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0861-z · Cited by 330
Shaw, E. G., Berkey, B., Coons, S. W., Bullard, D., Brachman, D., Buckner, J. C., Stelzer, K. J., Barger, G. R., Brown, P. D., Gilbert, M. R., et al. (2008) · Journal of Neurosurgery · doi:10.3171/jns/2008/109/11/0835 · Cited by 324
Craniotomy for Tumor Treatment in an Intraoperative Magnetic Resonance Imaging Unit
Black, P. M., Alexander, E., Martin, C., Moriarty, T., Nabavi, A., Wong, T. Z., Schwartz, R. B., & Jolesz, F. (1999) · Neurosurgery · doi:10.1097/00006123-199909000-00001 · Cited by 301
van den Bent, M. J., Taphoorn, M. J. B., Brandes, A. A., Menten, J., Stupp, R., Frenay, M., Chinot, O., Kros, J. M., van der Rijt, C. C. D., Vecht, C. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.015 · Cited by 297
Temozolomide for low-grade gliomas: Predictive impact of 1p/19q loss on response and outcome
Kaloshi, G., Benouaich-Amiel, A., Diakite, F., Taillibert, S., Lejeune, J., Laigle-Donadey, F., Renard, M.-A., Iraqi, W., Idbaih, A., Paris, S., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000262034.26310.a2 · Cited by 286
Pace, A., Vidiri, A., Galiè, E., Carosi, M., Telera, S., Cianciulli, A. M., Canalini, P., Giannarelli, D., Jandolo, B., & Carapella, C. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg502 · Cited by 263
Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas
Brada, M., Viviers, L., Abson, C., Hines, F., Britton, J., Ashley, S., Sardell, S., Traish, D., Gonsalves, A., Wilkins, P., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg371 · Cited by 261
Phase II Trial of Temozolomide in Patients With Progressive Low-Grade Glioma
Quinn, J. A., Reardon, D. A., Friedman, A. H., Rich, J. N., Sampson, J. H., Provenzale, J. M., McLendon, R. E., Gururangan, S., Bigner, D. D., Herndon, J. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.009 · Cited by 258
Pallud, J., Mandonnet, E., Duffau, H., Kujas, M., Guillevin, R., Galanaud, D., Taillandier, L., & Capelle, L. (2006) · Annals of Neurology · doi:10.1002/ana.20946 · Cited by 250
Variations in the History and Survival of Patients with, Supratentorial Low-grade Astrocytomas
Piepmeier, J., Susan Christopher, R. N., Spencer, D., Byrne, T., Kim, J., Knisel, J. P., Lacy, J., Tsukerman, L., & Makuch, R. (1996) · Neurosurgery · doi:10.1097/00006123-199605000-00002 · Cited by 249
Buckner, J. C., Gesme, D., O’Fallon, J. R., Hammack, J. E., Stafford, S., Brown, P. D., Hawkins, R., Scheithauer, B. W., Erickson, B. J., Levitt, R., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.023 · Cited by 249
Low-grade cerebral astrocytomas: Survival and quality of life after radiation therapy
North, C. A., North, R. B., Epstein, J. I., Piantadosi, S., & Wharam, M. D. (1990) · Cancer · Cited by 243
Danchaivijitr, N., Waldman, A. D., Tozer, D. J., Benton, C. E., Brasil Caseiras, G., Tofts, P. S., Rees, J. H., & Jäger, H. R. (2008) · Radiology · doi:10.1148/radiol.2471062089 · Cited by 238
Lote, K., Egeland, T., Hager, B., Stenwig, B., Skullerud, K., Berg-Johnsen, J., Storm-Mathisen, I., & Hirschberg, H. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.9.3129 · Cited by 236
Chang, E. F., Smith, J. S., Chang, S. M., Lamborn, K. R., Prados, M. D., Butowski, N., Barbaro, N. M., Parsa, A. T., Berger, M. S., & Mcdermott, M. M. (2008) · Journal of Neurosurgery · doi:10.3171/jns/2008/109/11/0817 · Cited by 234
Self-citationRobles, S. G., Gatignol, P., Lehéricy, S., & Duffau, H. (2008) · Journal of Neurosurgery · doi:10.3171/jns/2008/109/10/0615 · Cited by 232
van Veelen, M. L. C., Avezaat, C. J. J., Kros, J. M., van Putten, W., & Vecht, C. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.5.581 · Cited by 230
Claus, E. B., & Black, P. M. (2006) · Cancer · doi:10.1002/cncr.21733 · Cited by 226
Berger, M. S., Ghatan, S., Haglund, M. M., Dobbins, J., & Ojemann, G. A. (1993) · Journal of Neurosurgery · doi:10.3171/jns.1993.79.1.0062 · Cited by 223
Self-citationDuffau, H., Capelle, L., Sichez, J. P., Faillot, T., Abdennour, L., Law Koune, J.-D., Dadoun, S., Bitar, A., Arthuis, F., Van Effenterre, R., et al. (1999) · Acta Neurochirurgica · doi:10.1007/s007010050413 · Cited by 216
MGMT methylation: A marker of response to temozolomide in low‐grade gliomas
Everhard, S., Kaloshi, G., Crinière, E., Benouaich‐Amiel, A., Lejeune, J., Marie, Y., Sanson, M., Kujas, M., Mokhtari, K., Hoang‐Xuan, K., et al. (2006) · Annals of Neurology · doi:10.1002/ana.21044 · Cited by 215
Functional MRI of Language Processing: Dependence on Input Modality and Temporal Lobe Epilepsy
Carpentier, A., Pugh, K. R., Westerveld, M., Studholme, C., Skrinjar, O., Thompson, J. L., Spencer, D. D., & Constable, R. T. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.35500.x · Cited by 208
Cellular Telephone Use and Risk of Acoustic Neuroma
Christensen, H. C. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh032 · Cited by 202
Chaichana, K. L., McGirt, M. J., Laterra, J., Olivi, A., & Quiñones-Hinojosa, A. (2010) · Journal of Neurosurgery · doi:10.3171/2008.10.jns08608 · Cited by 192
IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide
Dubbink, H. J., Taal, W., van Marion, R., Kros, J. M., van Heuvel, I., Bromberg, J. E., Zonnenberg, B. A., Zonnenberg, C. B. L., Postma, T. J., Gijtenbeek, J. M. M., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c34ace · Cited by 188
Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors
Barker, F. G., Chang, S. M., Huhn, S. L., Davis, R. L., Gutin, P. H., McDermott, M. W., Wilson, C. B., & Prados, M. D. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970901)80:5<936::aid-cncr15>3.0.co;2-x · Cited by 187
Self-citationPrognostic Value of O-(2-18F-Fluoroethyl)-L-Tyrosine PET and MRI in Low-Grade Glioma
Floeth, F. W., Pauleit, D., Sabel, M., Stoffels, G., Reifenberger, G., Riemenschneider, M. J., Jansen, P., Coenen, H. H., Steiger, H.-J., & Langen, K.-J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037895 · Cited by 186
Low grade supratentorial astrocytomas. Management and prognostic factors
Janny, P., Cure, H., Mohr, M., Heldt, N., Kwiatkowski, F., Lemaire, J.-J., Plagne, R., & Rozan, R. (1994) · Cancer · doi:10.1002/1097-0142(19940401)73:7<1937::aid-cncr2820730727>3.0.co;2-g · Cited by 186
Bauman, G. S., Lote, K., Larson, D., Statpers, L., Leighton, C., Fisher, B., Wara, W., Macdonald, D., Stitt, L., & Cairncross, J. G. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)90145-1 · Cited by 176
Eyre, H. J., Crowley, J. J., Townsend, J. J., Eltringham, J. R., Morantz, R. A., Schulman, S. F., Quagliana, J. M., & Al-Sarraf, M. (1993) · Journal of Neurosurgery · doi:10.3171/jns.1993.78.6.0909 · Cited by 167
Molecular Classification and Survival Prediction in Human Gliomas Based on Proteome Analysis
Iwadate, Y., Sakaida, T., Hiwasa, T., Nagai, Y., Ishikura, H., Takiguchi, M., & Yamaura, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1254 · Cited by 164
Supratentorial grade II astrocytoma: biological features and clinical course
Wessels, P. H., Weber, W. E., Raven, G., Ramaekers, F. C., Hopman, A. H., & Twijnstra, A. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00434-4 · Cited by 162
Farrell, C. J., & Plotkin, S. R. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.07.008 · Cited by 162
Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma
Wiencke, J. K., Zheng, S., Jelluma, N., Tihan, T., Vandenberg, S., Tamgüney, T., Baumber, R., Parsons, R., Lamborn, K. R., Berger, M. S., et al. (2007) · Neuro-Oncology · doi:10.1215/15228517-2007-003 · Cited by 161
Self-citationClinicopathologic Aspects of 1p/19q Loss and the Diagnosis of Oligodendroglioma
Aldape, K., Burger, P. C., & Perry, A. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-242-caoqla · Cited by 153
Rees, J. H., Watt, H., Jäger, H. R., Benton, C., Tozer, D. J., Tofts, P. S., & Waldman, A. D. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.06.013 · Cited by 153
Gemistocytic astrocytomas: a reappraisal
Krouwer, H. G. J., Davis, R. L., Silver, P., & Prados, M. D. (1991) · Journal of neurosurgery · doi:10.3171/jns.1991.74.3.0399 · Cited by 148
Analysis of Prognostic and Survival Factors Related to Treatment of Low-Grade Astrocytomas in Adults
Nakamura, M., Konishi, N., Tsunoda, S., Nakase, H., Tsuzuki, T., Aoki, H., Sakitani, H., Inui, T., & Sakaki, T. (2000) · Oncology · doi:10.1159/000012087 · Cited by 147
Quiñones‐Hinojosa, A., Ojemann, S. G., Sanai, N., Dillon, W. P., & Berger, M. S. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.99.2.0311 · Cited by 137
Self-citationColman, H., Giannini, C., Huang, L., Gonzalez, J., Hess, K. R., Bruner, J., Fuller, G. N., Langford, L. A., Pelloski, C. E., Aaron, J., et al. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000202048.28203.25 · Cited by 137
Progressive low‐grade oligodendrogliomas
Levin, N., Lavon, I., Zelikovitsh, B., et al. (2006) · Cancer · doi:10.1002/cncr.21809 · Cited by 134
Treatment outcomes and prognostic factors in patients with supratentorial low-grade gliomas
Yeh, S.-A., Ho, J. D., Lui, C.-C., Huang, Y.-J., Hsiung, C.-Y., & Huang, E.-Y. (2005) · British Journal of Radiology · doi:10.1259/bjr/28534346 · Cited by 134
Insular gliomas: the case for surgical management
Simon, M., Neuloh, G., von Lehe, M., Meyer, B., & Schramm, J. (2008) · Journal of neurosurgery · doi:10.3171/2008.7.jns17639 · Cited by 132
Scerrati, M., Roselli, R., Iacoangeli, M., Pompucci, A., & Rossi, G. F. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.3.291 · Cited by 132
Johannesen, T. B., Langmark, F., & Lote, K. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.99.5.0854 · Cited by 131
Rebetz, J., Tian, D., Persson, A., Widegren, B., Salford, L. G., Englund, E. M., Gisselsson, D., & Fan, X. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001936 · Cited by 130
Stege, E. M. B., Kros, J. M., de Bruin, H. G., Enting, R. H., van Heuvel, I., Looijenga, L. H. J., van der Rijt, C. C. D., Smitt, P. A. E. S., & van den Bent, M. J. (2005) · Cancer · doi:10.1002/cncr.20828 · Cited by 126
Rezvan, A., Dictus, C., Hartmann, C. J., Zürn, O., Lutz, E., Marius, H., Stephanie, C., Christel, H.-M., Wirtz, C. R., & Andreas, U. (2009) · Acta Neurochirurgica · doi:10.1007/s00701-009-0435-x · Cited by 125
Outcome in adult low-grade glioma: The impact of prognostic factors and treatment
Schiff, D., Brown, P. D., & Giannini, C. (2007) · Neurology · doi:10.1212/01.wnl.0000277271.47601.a1 · Cited by 123
White, M. L., Zhang, Y., Kirby, P., & Ryken, T. C. (2005) · PubMed · Cited by 119
Herholz, K., Reulen, H., von Stockhausen, H.-M., Thiel, A., llmberger, J., Kessler, J., Eisner, W., Yousry, T. A., & Heiss, W. (1997) · Neurosurgery · doi:10.1097/00006123-199712000-00004 · Cited by 116
Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy
Pirzkall, A., Nelson, S. J., McKnight, T. R., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02869-9 · Cited by 116
MRI in treatment of adult gliomas
Henson, J. W., Gaviani, P., & González, R. G. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)01767-5 · Cited by 115
Kouwenhoven, M. C. M., Kros, J. M., French, P. J., Stege, E. M. B., Graveland, W. J., TAPHOORN, M. J. B., Brandes, A. A., & van den Bent, M. J. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.05.021 · Cited by 115
Sugano, H., Shimizu, H., & Sunaga, S. (2006) · Seizure · doi:10.1016/j.seizure.2006.10.010 · Cited by 108
Low-Grade Glioma on Stereotactic Biopsy: How Often is the Diagnosis Accurate?
Muragaki, Y., Chernov, M., Maruyama, T., Ochiai, T., Taira, T., Kubo, O., Nakamura, R., Iseki, H., Hori, T., & Takakura, K. (2008) · min - Minimally Invasive Neurosurgery · doi:10.1055/s-0028-1082322 · Cited by 107
Prognostic value of choline and creatine in WHO grade II gliomas
Hattingen, E., Raab, P., Franz, K., Lanfermann, H., Setzer, M., Gerlach, R., Zanella, F. E., & Pilatus, U. (2008) · Neuroradiology · doi:10.1007/s00234-008-0409-3 · Cited by 104
Metabolic and molecular imaging in neuro-oncology
Herholz, K., Coope, D. J., & Jackson, A. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70192-8 · Cited by 100
Caseiras, G. B., Ciccarelli, O., Altmann, D. R., Benton, C. E., Tozer, D. J., Tofts, P. S., Yousry, T. A., Rees, J. H., Waldman, A. D., & Jäger, H. R. (2009) · Radiology · doi:10.1148/radiol.2532081623 · Cited by 99
Surgery Insight: the role of surgery in the management of low-grade gliomas
Pouratian, N., Asthagiri, A. R., Jagannathan, J., Shaffrey, M. E., & Schiff, D. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0634 · Cited by 96
Chang, E. F., Clark, A., Jensen, R. L., Bernstein, M., Guha, A., Carrabba, G. G., Mukhopadhyay, D., Kim, W. B., Liau, L. M., Chang, S. M., et al. (2009) · Journal of neurosurgery · doi:10.3171/2009.2.jns081101 · Cited by 90
Self-citationWiemels, J. L., Wilson, D., Patil, C. G., Patoka, J., Mccoy, L. S., Rice, T., Schwartzbaum, J., Heimberger, A. B., Sampson, J. H., Chang, S. M., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24369 · Cited by 89
Self-citationKi-67: a prognostic factor for low-grade glioma?
Fisher, B. J., Naumova, E., Leighton, C. C., Naumov, G. N., Kerklviet, N., Fortin, D., Macdonald, D. R., Cairncross, J. G., Bauman, G. S., & Stitt, L. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)02720-1 · Cited by 87
The management of histologically unverified presumed cerebral gliomas with radiotherapy
Rajan, B., Pickuth, D., Ashley, S., Traish, D., Monro, P., Elyan, S., & Brada, M. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90064-7 · Cited by 87
Barnholtz‐Sloan, J. S., Sloan, A. E., & Schwartz, A. G. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.99.3.0458 · Cited by 83
Mariani, L., Deiana, G., Vassella, E., Fathi, A.-R., Murtin, C., Arnold, M., Vajtai, I., Weis, J., Siegenthaler, P., Schobesberger, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9238 · Cited by 83
Tosoni, A., Franceschi, E., Ermani, M., Bertorelle, R., Bonaldi, L., Blatt, V., & Brandes, A. A. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9600-y · Cited by 78
Wrensch, M., Rice, T., Miike, R., McMillan, A., Lamborn, K. R., Aldape, K., & Prados, M. D. (2006) · Neuro-Oncology · doi:10.1215/s1522851705000268 · Cited by 78
Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival
McBride, S. M., Perez, D. A., Polley, M. C., VandenBerg, S. R., Smith, J. S., Zheng, S., Lamborn, K. R., Wiencke, J. K., Chang, S. M., Prados, M. D., et al. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0004-4 · Cited by 78
Self-citationProton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas
Guillevin, R., Guillevin, C., Duffau, H., Kujas, M., Capelle, L., Aubert, A., Taillibert, S., Idbaïh, A., Pallud, J., de Marco, G., et al. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9508-y · Cited by 78
Adult Supratentorial Low-Grade Glioma: Long-Term Experience at a Single Institution
Bauman, G. S., Fisher, B., Watling, C., Cairncross, J. G., & Macdonald, D. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.01.010 · Cited by 76
Issues of Diagnostic Review in Brain Tumor Studies: From the Brain Tumor Epidemiology Consortium
Davis, F. G., Malmer, B., Aldape, K. D., Barnholtz‐Sloan, J. S., Bondy, M. L., Brännström, T., Bruner, J. M., Burger, P. C., Collins, V. P., Inskip, P. D., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0725 · Cited by 71
Varela, M. S., Ranuncolo, S. M., Morand, A., Lastiri, J. M., Joffé, E. B. D. K., Puricelli, L., & Pallotta, M. G. (2004) · Journal of Surgical Oncology · doi:10.1002/jso.20036 · Cited by 68
Genomic changes in progression of low-grade gliomas
Idbaïh, A., Silva, R. C., Crinière, E., Marie, Y., Carpentier, C., Boisselier, B., Taillibert, S., Rousseau, A., Mokhtari, K., Ducray, F., et al. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9644-z · Cited by 57
Watanabe, T., Katayama, Y., Yoshino, A., Yachi, K., Ohta, T., Ogino, A., Komine, C., & Fukushima, T. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00030.x · Cited by 57
Gelpí, E., Ambros, I. M., Birner, P., Luegmayr, A., Drlicek, M., Fischer, I., Kleinert, R., Maier, H., Huemer, M., Gatterbauer, B., et al. (2003) · Modern Pathology · doi:10.1097/01.mp.0000076981.90281.bf · Cited by 54
Weller, M., Wick, W., & von Deimling, A. (2011) · Glia · doi:10.1002/glia.21130 · Cited by 54
Grade II astrocytomas are subgrouped by chromosome aberrations
Hirose, Y., Aldape, K., Chang, S. M., Lamborn, K. R., Berger, M. S., & Feuerstein, B. G. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00791-4 · Cited by 53
Self-citationCowell, J. K., Barnett, G. H., & Nowak, N. J. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.2.151 · Cited by 52
The role of stereotactic radiosurgery for low-grade astrocytomas
Hadjipanayis, C. G., Kondziolka, D. S., Flíckinger, J. C., & Lunsford, L. D. (2003) · Neurosurgical FOCUS · doi:10.3171/foc.2003.14.5.16 · Cited by 50
DNA methylation in brain development and gliomagenesis
Costello, J. (2003) · Frontiers in bioscience · doi:10.2741/1027 · Cited by 47
Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors
Walker, C. A., Haylock, B. J., Husband, D. J., Joyce, K. A., Fildes, D., Jenkinson, M. D., Smith, T., Broome, J. C., du Plessis, D. G., & Warnke, P. C. (2006) · Neurology · doi:10.1212/01.wnl.0000218270.12495.9a · Cited by 44
Ruiz, J., & Lesser, G. J. (2009) · Current Treatment Options in Oncology · doi:10.1007/s11864-009-0096-2 · Cited by 43
Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas
Khayal, I. S., McKnight, T. R., McGue, C., VandenBerg, S. R., Lamborn, K. R., Chang, S. M., Cha, S., & Nelson, S. J. (2009) · NMR in Biomedicine · doi:10.1002/nbm.1357 · Cited by 42
Self-citationLow-grade gliomas in older patients: a retrospective analysis of prognostic factors
Pouratian, N., Mut, M., Jagannathan, J., Lopes, M. B. S., Shaffrey, M. E., & Schiff, D. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9669-3 · Cited by 42
Talos, I., Zou, K. H., Kikinis, R., & Jolesz, F. A. (2007) · Academic Radiology · doi:10.1016/j.acra.2007.01.033 · Cited by 39
Tofts, P. S., Benton, C. E., Weil, R. S., et al. (2006) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20800 · Cited by 38
Diagnosis and management of oligodendroglioma
van den Bent, M. J. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.07.006 · Cited by 34
Nakasu, S., Fukami, T., Jito, J., & Matsuda, M. (2007) · Surgical Neurology · doi:10.1016/j.surneu.2006.12.053 · Cited by 30
Lessons learned from randomised clinical trials in adult low grade glioma
Papagikos, M. A., Shaw, E. G., & Stieber, V. W. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70095-4 · Cited by 29
Using Neurofibromatosis-1 to Better Understand and Treat Pediatric Low-Grade Glioma
Gutmann, D. H. (2008) · Journal of Child Neurology · doi:10.1177/0883073808321061 · Cited by 28
Brain tumors: molecular biology and targeted therapies
Hegi, M. E., Murat, A., Lambiv, W. L., & Stupp, R. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl259 · Cited by 27
Payne, C. A., Maleki, S., Messina, M., O’Sullivan, M. G., Stone, G., Hall, N. R., Parkinson, J., Wheeler, H., Cook, R., Biggs, M. T., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0629 · Cited by 27
Low-grade glioma: a challenge in therapeutic options: the role of radiotherapy
Baumert, B. G., & Stupp, R. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn434 · Cited by 26
Yang, J., Liao, D., Wang, Z., Liu, F., & Wu, G. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.06.025 · Cited by 21
Tenascin‐C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas
Maris, C., Rorive, S., Sandras, F., D’Haene, N., Sadeghi, N., Bièche, I., Vidaud, M., Decaestecker, C., & Salmon, I. J. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00898.x · Cited by 18
Signal transduction molecules in gliomas of all grades
Ermoian, R. P., Kaprealian, T. B., Lamborn, K. R., Yang, X., Jelluma, N., Arvold, N. D., Zeidman, R., Berger, M. S., Stokoe, D., & Haas-Kogan, D. A. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9683-5 · Cited by 17
Self-citationIs there a place for radiotherapy in low-grade gliomas?
Baumert, B. G., & Stupp, R. (2010) · Advances and technical standards in neurosurgery · doi:10.1007/978-3-211-99481-8_6 · Cited by 16
Chemotherapy in adults with gliomas.
See, S. J., & Gilbert, M. R. (2007) · PubMed · Cited by 15
Chromosome 1p and 19q evaluation in low-grade oligodendrogliomas: A descriptive study
Calistri (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000324 · Cited by 14
Low grade supratentorial astrocytomas: Management and prognostic factors
Kreth, F. W., Warnke, P. C., & Ostertag, C. B. (1994) · Cancer · doi:10.1002/1097-0142(19941215)74:12<3247::aid-cncr2820741227>3.0.co;2-j · Cited by 14
Berger (1994) · doi:10.1002/1097-0142(19940915)74:6<1784::aid-cncr2820740622>3.0.co;2-d
Cited by
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
The Cancer Genome Atlas Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402121 · Cited by 3,148
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
Johnson, B. E., Mazor, T., Hong, C., Barnes, M., Aihara, K., McLean, C. Y., Fouse, S. D., Yamamoto, S., Ueda, H., Tatsuno, K., et al. (2014) · Science · doi:10.1126/science.1239947 · Cited by 1,362
Self-citationOvercoming the blood–brain tumor barrier for effective glioblastoma treatment
van Tellingen, O., Yetkin-Arik, B., de Gooijer, M. C., Wesseling, P., Wurdinger, T., & de Vries, H. E. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.02.002 · Cited by 1,035
Jakola, A. S., Myrmel, K. S., Kloster, R., Torp, S. H., Lindal, S., Unsgård, G., & Solheim, O. (2012) · JAMA · doi:10.1001/jama.2012.12807 · Cited by 641
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas
Kohanbash, G., Carrera, D. A., Shrivastav, S., Ahn, B. J., Jahan, N., Mazor, T., Chheda, Z. S., Downey, K. M., Watchmaker, P. B., Beppler, C., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90644 · Cited by 410
Metadata
- Authors
- Sanai, N., Chang, S., & Berger, M. S.
- Venue
- Journal of Neurosurgery
- Published
- 2011-11
- Volume
- 115
- Issue
- 5
- Pages
- 948-965
- ISSN
- 0022-3085 (ISSN-L)
- 1933-0693
- OpenAlex
- W2096946132
- Cited by
- 291
- References
- 138
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.